APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transthyretin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Transthyretin Market Analysis and Forecast 2026-2032

22 December 2025196 pages

Choose your research edition.

Industry ResearchTransthyretin Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Transthyretin Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Transthyretin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transthyretin Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Transthyretin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Transthyretin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Transthyretin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Transthyretin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Transthyretin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Transthyretin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Transthyretin include Alnylam Pharmaceuticals Inc, Arcturus Therapeutics Inc, Ionis Pharmaceuticals Inc, Neurimmune Holding AG, Prothena Corp Plc, Regeneron Pharmaceuticals Inc and Pfizer Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Transthyretin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Transthyretin, also provides the sales of main regions and countries. Of the upcoming market potential for Transthyretin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transthyretin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Transthyretin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Transthyretin sales, projected growth trends, production technology, application and end-user industry.

Transthyretin Segment by Company

Alnylam Pharmaceuticals Inc

Arcturus Therapeutics Inc

Ionis Pharmaceuticals Inc

Neurimmune Holding AG

Prothena Corp Plc

Regeneron Pharmaceuticals Inc

Pfizer Inc

Transthyretin Segment by Type

AG-10

Inotersen Sodium

EDE-1307

CRX-1008

ALN-TTRsc02

Others

Transthyretin Segment by Application

Alzheimer's Disease

Familial Amyloid Neuropathies

Cardomyopathy

Neuropathy

Others

Transthyretin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transthyretin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transthyretin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transthyretin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Transthyretin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Transthyretin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transthyretin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Transthyretin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. AG-10 Major Manufacturers Table 3. Inotersen Sodium Major Manufacturers Table 4. EDE-1307 Major Manufacturers Table 5. CRX-1008 Major Manufacturers Table 6. ALN-TTRsc02 Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Transthyretin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Alzheimer's Disease Major Manufacturers Table 10. Familial Amyloid Neuropathies Major Manufacturers Table 11. Cardomyopathy Major Manufacturers Table 12. Neuropathy Major Manufacturers Table 13. Others Major Manufacturers Table 14. Transthyretin Industry Trends Table 15. Transthyretin Industry Drivers Table 16. Transthyretin Industry Opportunities and Challenges Table 17. Transthyretin Industry Restraints Table 18. Global Transthyretin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Transthyretin Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Transthyretin Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Transthyretin Revenue Market Share by Region (2021-2026) Table 22. Global Transthyretin Revenue Market Share by Region (2027-2032) Table 23. Global Transthyretin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 24. Global Transthyretin Sales by Region (2021-2026) & (k units) Table 25. Global Transthyretin Sales by Region (2027-2032) & (k units) Table 26. Global Transthyretin Sales Market Share by Region (2021-2026) Table 27. Global Transthyretin Sales Market Share by Region (2027-2032) Table 28. Global Transthyretin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Transthyretin Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Transthyretin Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Transthyretin Sales Market Share by Manufacturers (2021-2026) Table 32. Global Transthyretin Sales Price (US$/unit) of Manufacturers (2021-2026) Table 33. Global Transthyretin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Transthyretin Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Transthyretin Manufacturers, Product Type & Application Table 36. Global Transthyretin Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Transthyretin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Transthyretin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Transthyretin Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Transthyretin Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Transthyretin Revenue Market Share by Type (2021-2026) Table 43. Global Transthyretin Revenue Market Share by Type (2027-2032) Table 44. Global Transthyretin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 45. Global Transthyretin Sales by Type (2021-2026) & (k units) Table 46. Global Transthyretin Sales by Type (2027-2032) & (k units) Table 47. Global Transthyretin Sales Market Share by Type (2021-2026) Table 48. Global Transthyretin Sales Market Share by Type (2027-2032) Table 49. Global Transthyretin Price by Type (2021-2026) & (US$/unit) Table 50. Global Transthyretin Price by Type (2027-2032) & (US$/unit) Table 51. Global Transthyretin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Transthyretin Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Transthyretin Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Transthyretin Revenue Market Share by Application (2021-2026) Table 55. Global Transthyretin Revenue Market Share by Application (2027-2032) Table 56. Global Transthyretin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 57. Global Transthyretin Sales by Application (2021-2026) & (k units) Table 58. Global Transthyretin Sales by Application (2027-2032) & (k units) Table 59. Global Transthyretin Sales Market Share by Application (2021-2026) Table 60. Global Transthyretin Sales Market Share by Application (2027-2032) Table 61. Global Transthyretin Price by Application (2021-2026) & (US$/unit) Table 62. Global Transthyretin Price by Application (2027-2032) & (US$/unit) Table 63. Alnylam Pharmaceuticals Inc Company Information Table 64. Alnylam Pharmaceuticals Inc Business Overview Table 65. Alnylam Pharmaceuticals Inc Transthyretin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Alnylam Pharmaceuticals Inc Transthyretin Product Portfolio Table 67. Alnylam Pharmaceuticals Inc Recent Development Table 68. Arcturus Therapeutics Inc Company Information Table 69. Arcturus Therapeutics Inc Business Overview Table 70. Arcturus Therapeutics Inc Transthyretin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Arcturus Therapeutics Inc Transthyretin Product Portfolio Table 72. Arcturus Therapeutics Inc Recent Development Table 73. Ionis Pharmaceuticals Inc Company Information Table 74. Ionis Pharmaceuticals Inc Business Overview Table 75. Ionis Pharmaceuticals Inc Transthyretin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Ionis Pharmaceuticals Inc Transthyretin Product Portfolio Table 77. Ionis Pharmaceuticals Inc Recent Development Table 78. Neurimmune Holding AG Company Information Table 79. Neurimmune Holding AG Business Overview Table 80. Neurimmune Holding AG Transthyretin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Neurimmune Holding AG Transthyretin Product Portfolio Table 82. Neurimmune Holding AG Recent Development Table 83. Prothena Corp Plc Company Information Table 84. Prothena Corp Plc Business Overview Table 85. Prothena Corp Plc Transthyretin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Prothena Corp Plc Transthyretin Product Portfolio Table 87. Prothena Corp Plc Recent Development Table 88. Regeneron Pharmaceuticals Inc Company Information Table 89. Regeneron Pharmaceuticals Inc Business Overview Table 90. Regeneron Pharmaceuticals Inc Transthyretin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Regeneron Pharmaceuticals Inc Transthyretin Product Portfolio Table 92. Regeneron Pharmaceuticals Inc Recent Development Table 93. Pfizer Inc Company Information Table 94. Pfizer Inc Business Overview Table 95. Pfizer Inc Transthyretin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Pfizer Inc Transthyretin Product Portfolio Table 97. Pfizer Inc Recent Development Table 98. North America Transthyretin Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Transthyretin Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Transthyretin Sales by Type (2021-2026) & (k units) Table 101. North America Transthyretin Sales by Type (2027-2032) & (k units) Table 102. North America Transthyretin Sales Price by Type (2021-2026) & (US$/unit) Table 103. North America Transthyretin Sales Price by Type (2027-2032) & (US$/unit) Table 104. North America Transthyretin Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Transthyretin Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Transthyretin Sales by Application (2021-2026) & (k units) Table 107. North America Transthyretin Sales by Application (2027-2032) & (k units) Table 108. North America Transthyretin Sales Price by Application (2021-2026) & (US$/unit) Table 109. North America Transthyretin Sales Price by Application (2027-2032) & (US$/unit) Table 110. North America Transthyretin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Transthyretin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Transthyretin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Transthyretin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 114. North America Transthyretin Sales by Country (2021-2026) & (k units) Table 115. North America Transthyretin Sales by Country (2027-2032) & (k units) Table 116. North America Transthyretin Sales Price by Country (2021-2026) & (US$/unit) Table 117. North America Transthyretin Sales Price by Country (2027-2032) & (US$/unit) Table 118. United States Transthyretin Revenue (2021-2032) & (US$ Million) Table 119. Canada Transthyretin Revenue (2021-2032) & (US$ Million) Table 120. Mexico Transthyretin Revenue (2021-2032) & (US$ Million) Table 121. Europe Transthyretin Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Transthyretin Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Transthyretin Sales by Type (2021-2026) & (k units) Table 124. Europe Transthyretin Sales by Type (2027-2032) & (k units) Table 125. Europe Transthyretin Sales Price by Type (2021-2026) & (US$/unit) Table 126. Europe Transthyretin Sales Price by Type (2027-2032) & (US$/unit) Table 127. Europe Transthyretin Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Transthyretin Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Transthyretin Sales by Application (2021-2026) & (k units) Table 130. Europe Transthyretin Sales by Application (2027-2032) & (k units) Table 131. Europe Transthyretin Sales Price by Application (2021-2026) & (US$/unit) Table 132. Europe Transthyretin Sales Price by Application (2027-2032) & (US$/unit) Table 133. Europe Transthyretin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Transthyretin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Transthyretin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Transthyretin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 137. Europe Transthyretin Sales by Country (2021-2026) & (k units) Table 138. Europe Transthyretin Sales by Country (2027-2032) & (k units) Table 139. Europe Transthyretin Sales Price by Country (2021-2026) & (US$/unit) Table 140. Europe Transthyretin Sales Price by Country (2027-2032) & (US$/unit) Table 141. Germany Transthyretin Revenue (2021-2032) & (US$ Million) Table 142. France Transthyretin Revenue (2021-2032) & (US$ Million) Table 143. U.K. Transthyretin Revenue (2021-2032) & (US$ Million) Table 144. Italy Transthyretin Revenue (2021-2032) & (US$ Million) Table 145. Russia Transthyretin Revenue (2021-2032) & (US$ Million) Table 146. Spain Transthyretin Revenue (2021-2032) & (US$ Million) Table 147. Netherlands Transthyretin Revenue (2021-2032) & (US$ Million) Table 148. Switzerland Transthyretin Revenue (2021-2032) & (US$ Million) Table 149. Sweden Transthyretin Revenue (2021-2032) & (US$ Million) Table 150. Poland Transthyretin Revenue (2021-2032) & (US$ Million) Table 151. China Transthyretin Revenue by Type (2021-2026) & (US$ Million) Table 152. China Transthyretin Revenue by Type (2027-2032) & (US$ Million) Table 153. China Transthyretin Sales by Type (2021-2026) & (k units) Table 154. China Transthyretin Sales by Type (2027-2032) & (k units) Table 155. China Transthyretin Sales Price by Type (2021-2026) & (US$/unit) Table 156. China Transthyretin Sales Price by Type (2027-2032) & (US$/unit) Table 157. China Transthyretin Revenue by Application (2021-2026) & (US$ Million) Table 158. China Transthyretin Revenue by Application (2027-2032) & (US$ Million) Table 159. China Transthyretin Sales by Application (2021-2026) & (k units) Table 160. China Transthyretin Sales by Application (2027-2032) & (k units) Table 161. China Transthyretin Sales Price by Application (2021-2026) & (US$/unit) Table 162. China Transthyretin Sales Price by Application (2027-2032) & (US$/unit) Table 163. Asia Transthyretin Revenue by Type (2021-2026) & (US$ Million) Table 164. Asia Transthyretin Revenue by Type (2027-2032) & (US$ Million) Table 165. Asia Transthyretin Sales by Type (2021-2026) & (k units) Table 166. Asia Transthyretin Sales by Type (2027-2032) & (k units) Table 167. Asia Transthyretin Sales Price by Type (2021-2026) & (US$/unit) Table 168. Asia Transthyretin Sales Price by Type (2027-2032) & (US$/unit) Table 169. Asia Transthyretin Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia Transthyretin Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia Transthyretin Sales by Application (2021-2026) & (k units) Table 172. Asia Transthyretin Sales by Application (2027-2032) & (k units) Table 173. Asia Transthyretin Sales Price by Application (2021-2026) & (US$/unit) Table 174. Asia Transthyretin Sales Price by Application (2027-2032) & (US$/unit) Table 175. Asia Transthyretin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Asia Transthyretin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Asia Transthyretin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Asia Transthyretin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 179. Asia Transthyretin Sales by Country (2021-2026) & (k units) Table 180. Asia Transthyretin Sales by Country (2027-2032) & (k units) Table 181. Asia Transthyretin Sales Price by Country (2021-2026) & (US$/unit) Table 182. Asia Transthyretin Sales Price by Country (2027-2032) & (US$/unit) Table 183. Japan Transthyretin Revenue (2021-2032) & (US$ Million) Table 184. South Korea Transthyretin Revenue (2021-2032) & (US$ Million) Table 185. India Transthyretin Revenue (2021-2032) & (US$ Million) Table 186. Australia Transthyretin Revenue (2021-2032) & (US$ Million) Table 187. Taiwan Transthyretin Revenue (2021-2032) & (US$ Million) Table 188. Southeast Asia Transthyretin Revenue (2021-2032) & (US$ Million) Table 189. SAMEA Transthyretin Revenue by Type (2021-2026) & (US$ Million) Table 190. SAMEA Transthyretin Revenue by Type (2027-2032) & (US$ Million) Table 191. SAMEA Transthyretin Sales by Type (2021-2026) & (k units) Table 192. SAMEA Transthyretin Sales by Type (2027-2032) & (k units) Table 193. SAMEA Transthyretin Sales Price by Type (2021-2026) & (US$/unit) Table 194. SAMEA Transthyretin Sales Price by Type (2027-2032) & (US$/unit) Table 195. SAMEA Transthyretin Revenue by Application (2021-2026) & (US$ Million) Table 196. SAMEA Transthyretin Revenue by Application (2027-2032) & (US$ Million) Table 197. SAMEA Transthyretin Sales by Application (2021-2026) & (k units) Table 198. SAMEA Transthyretin Sales by Application (2027-2032) & (k units) Table 199. SAMEA Transthyretin Sales Price by Application (2021-2026) & (US$/unit) Table 200. SAMEA Transthyretin Sales Price by Application (2027-2032) & (US$/unit) Table 201. SAMEA Transthyretin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. SAMEA Transthyretin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. SAMEA Transthyretin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. SAMEA Transthyretin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 205. SAMEA Transthyretin Sales by Country (2021-2026) & (k units) Table 206. SAMEA Transthyretin Sales by Country (2027-2032) & (k units) Table 207. SAMEA Transthyretin Sales Price by Country (2021-2026) & (US$/unit) Table 208. SAMEA Transthyretin Sales Price by Country (2027-2032) & (US$/unit) Table 209. Brazil Transthyretin Revenue (2021-2032) & (US$ Million) Table 210. Argentina Transthyretin Revenue (2021-2032) & (US$ Million) Table 211. Chile Transthyretin Revenue (2021-2032) & (US$ Million) Table 212. Colombia Transthyretin Revenue (2021-2032) & (US$ Million) Table 213. Peru Transthyretin Revenue (2021-2032) & (US$ Million) Table 214. Saudi Arabia Transthyretin Revenue (2021-2032) & (US$ Million) Table 215. Israel Transthyretin Revenue (2021-2032) & (US$ Million) Table 216. UAE Transthyretin Revenue (2021-2032) & (US$ Million) Table 217. Turkey Transthyretin Revenue (2021-2032) & (US$ Million) Table 218. Iran Transthyretin Revenue (2021-2032) & (US$ Million) Table 219. Egypt Transthyretin Revenue (2021-2032) & (US$ Million) Table 220. Key Raw Materials Table 221. Raw Materials Key Suppliers Table 222. Transthyretin Distributors List Table 223. Transthyretin Customers List Table 224. Research Programs/Design for This Report Table 225. Authors List of This Report Table 226. Secondary Sources Table 227. Primary Sources List of Figures Figure 1. Transthyretin Image Figure 2. Global Transthyretin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transthyretin Market Size Share 2021 VS 2025 VS 2032 Figure 4. AG-10 Image Figure 5. Inotersen Sodium Image Figure 6. EDE-1307 Image Figure 7. CRX-1008 Image Figure 8. ALN-TTRsc02 Image Figure 9. Others Image Figure 10. Global Transthyretin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Transthyretin Market Size Share 2021 VS 2025 VS 2032 Figure 12. Alzheimer's Disease Image Figure 13. Familial Amyloid Neuropathies Image Figure 14. Cardomyopathy Image Figure 15. Neuropathy Image Figure 16. Others Image Figure 17. Global Transthyretin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Transthyretin Revenue (2021-2032) & (US$ Million) Figure 19. Global Transthyretin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Transthyretin Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Transthyretin Revenue Market Share by Region (2021-2032) Figure 22. Global Transthyretin Sales (2021-2032) & (k units) Figure 23. Global Transthyretin Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 24. Global Transthyretin Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Transthyretin Sales YoY (2021-2032) & (k units) Figure 26. Europe Transthyretin Sales YoY (2021-2032) & (k units) Figure 27. China Transthyretin Sales YoY (2021-2032) & (k units) Figure 28. Asia (Excluding China) Transthyretin Sales YoY (2021-2032) & (k units) Figure 29. South America, Middle East and Africa Transthyretin Sales YoY (2021-2032) & (k units) Figure 30. Global Transthyretin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Transthyretin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Transthyretin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Transthyretin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Transthyretin Revenue Market Share by Type (2021-2032) Figure 36. Global Transthyretin Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Transthyretin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Transthyretin Sales Market Share by Type (2021-2032) Figure 39. Global Transthyretin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Transthyretin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Transthyretin Revenue Market Share by Application (2021-2032) Figure 42. Global Transthyretin Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 43. Global Transthyretin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Transthyretin Sales Market Share by Application (2021-2032) Figure 45. North America Transthyretin Revenue Share by Type (2021-2032) Figure 46. North America Transthyretin Sales Share by Type (2021-2032) Figure 47. North America Transthyretin Revenue Share by Application (2021-2032) Figure 48. North America Transthyretin Sales Share by Application (2021-2032) Figure 49. North America Transthyretin Revenue Share by Country (2021-2032) Figure 50. North America Transthyretin Sales Share by Country (2021-2032) Figure 51. Europe Transthyretin Revenue Share by Type (2021-2032) Figure 52. Europe Transthyretin Sales Share by Type (2021-2032) Figure 53. Europe Transthyretin Revenue Share by Application (2021-2032) Figure 54. Europe Transthyretin Sales Share by Application (2021-2032) Figure 55. Europe Transthyretin Revenue Share by Country (2021-2032) Figure 56. Europe Transthyretin Sales Share by Country (2021-2032) Figure 57. China Transthyretin Revenue Share by Type (2021-2032) Figure 58. China Transthyretin Sales Share by Type (2021-2032) Figure 59. China Transthyretin Revenue Share by Application (2021-2032) Figure 60. China Transthyretin Sales Share by Application (2021-2032) Figure 61. Asia Transthyretin Revenue Share by Type (2021-2032) Figure 62. Asia Transthyretin Sales Share by Type (2021-2032) Figure 63. Asia Transthyretin Revenue Share by Application (2021-2032) Figure 64. Asia Transthyretin Sales Share by Application (2021-2032) Figure 65. Asia Transthyretin Revenue Share by Country (2021-2032) Figure 66. Asia Transthyretin Sales Share by Country (2021-2032) Figure 67. SAMEA Transthyretin Revenue Share by Type (2021-2032) Figure 68. SAMEA Transthyretin Sales Share by Type (2021-2032) Figure 69. SAMEA Transthyretin Revenue Share by Application (2021-2032) Figure 70. SAMEA Transthyretin Sales Share by Application (2021-2032) Figure 71. SAMEA Transthyretin Revenue Share by Country (2021-2032) Figure 72. SAMEA Transthyretin Sales Share by Country (2021-2032) Figure 73. Transthyretin Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Transthyretin Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • AG-10
  • Inotersen Sodium
  • EDE-1307
  • CRX-1008
  • ALN-TTRsc02
  • Others
Applications
  • Alzheimer's Disease
  • Familial Amyloid Neuropathies
  • Cardomyopathy
  • Neuropathy
  • Others
Companies covered
  • Alnylam Pharmaceuticals Inc
  • Arcturus Therapeutics Inc
  • Ionis Pharmaceuticals Inc
  • Neurimmune Holding AG
  • Prothena Corp Plc
  • Regeneron Pharmaceuticals Inc
  • Pfizer Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Transthyretin Market by Type
  3. 1.2.1 Global Transthyretin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 AG-10
  5. 1.2.3 Inotersen Sodium
  6. 1.2.4 EDE-1307
  7. 1.2.5 CRX-1008
  8. 1.2.6 ALN-TTRsc02
  9. 1.2.7 Others
  10. 1.3 Transthyretin Market by Application
  11. 1.3.1 Global Transthyretin Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Alzheimer's Disease
  13. 1.3.3 Familial Amyloid Neuropathies
  14. 1.3.4 Cardomyopathy
  15. 1.3.5 Neuropathy
  16. 1.3.6 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Transthyretin Market Dynamics
  1. 2.1 Transthyretin Industry Trends
  2. 2.2 Transthyretin Industry Drivers
  3. 2.3 Transthyretin Industry Opportunities and Challenges
  4. 2.4 Transthyretin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Transthyretin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Transthyretin Revenue by Region
  3. 3.2.1 Global Transthyretin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Transthyretin Revenue by Region (2021-2026)
  5. 3.2.3 Global Transthyretin Revenue by Region (2027-2032)
  6. 3.2.4 Global Transthyretin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Transthyretin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Transthyretin Sales by Region
  9. 3.4.1 Global Transthyretin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Transthyretin Sales by Region (2021-2026)
  11. 3.4.3 Global Transthyretin Sales by Region (2027-2032)
  12. 3.4.4 Global Transthyretin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Transthyretin Revenue by Manufacturers
  2. 4.1.1 Global Transthyretin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Transthyretin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Transthyretin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Transthyretin Sales by Manufacturers
  6. 4.2.1 Global Transthyretin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Transthyretin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Transthyretin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Transthyretin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Transthyretin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Transthyretin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Transthyretin Manufacturers, Product Type & Application
  13. 4.7 Global Transthyretin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Transthyretin Market CR5 and HHI
  16. 4.8.2 2025 Transthyretin Tier 1, Tier 2, and Tier 3
5 Transthyretin Market by Type
  1. 5.1 Global Transthyretin Revenue by Type
  2. 5.1.1 Global Transthyretin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Transthyretin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Transthyretin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Transthyretin Sales by Type
  6. 5.2.1 Global Transthyretin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Transthyretin Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Transthyretin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Transthyretin Price by Type
6 Transthyretin Market by Application
  1. 6.1 Global Transthyretin Revenue by Application
  2. 6.1.1 Global Transthyretin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Transthyretin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Transthyretin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Transthyretin Sales by Application
  6. 6.2.1 Global Transthyretin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Transthyretin Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Transthyretin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Transthyretin Price by Application
7 Company Profiles
  1. 7.1 Alnylam Pharmaceuticals Inc
  2. 7.1.1 Alnylam Pharmaceuticals Inc Company Information
  3. 7.1.2 Alnylam Pharmaceuticals Inc Business Overview
  4. 7.1.3 Alnylam Pharmaceuticals Inc Transthyretin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Alnylam Pharmaceuticals Inc Transthyretin Product Portfolio
  6. 7.1.5 Alnylam Pharmaceuticals Inc Recent Developments
  7. 7.2 Arcturus Therapeutics Inc
  8. 7.2.1 Arcturus Therapeutics Inc Company Information
  9. 7.2.2 Arcturus Therapeutics Inc Business Overview
  10. 7.2.3 Arcturus Therapeutics Inc Transthyretin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Arcturus Therapeutics Inc Transthyretin Product Portfolio
  12. 7.2.5 Arcturus Therapeutics Inc Recent Developments
  13. 7.3 Ionis Pharmaceuticals Inc
  14. 7.3.1 Ionis Pharmaceuticals Inc Company Information
  15. 7.3.2 Ionis Pharmaceuticals Inc Business Overview
  16. 7.3.3 Ionis Pharmaceuticals Inc Transthyretin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Ionis Pharmaceuticals Inc Transthyretin Product Portfolio
  18. 7.3.5 Ionis Pharmaceuticals Inc Recent Developments
  19. 7.4 Neurimmune Holding AG
  20. 7.4.1 Neurimmune Holding AG Company Information
  21. 7.4.2 Neurimmune Holding AG Business Overview
  22. 7.4.3 Neurimmune Holding AG Transthyretin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Neurimmune Holding AG Transthyretin Product Portfolio
  24. 7.4.5 Neurimmune Holding AG Recent Developments
  25. 7.5 Prothena Corp Plc
  26. 7.5.1 Prothena Corp Plc Company Information
  27. 7.5.2 Prothena Corp Plc Business Overview
  28. 7.5.3 Prothena Corp Plc Transthyretin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Prothena Corp Plc Transthyretin Product Portfolio
  30. 7.5.5 Prothena Corp Plc Recent Developments
  31. 7.6 Regeneron Pharmaceuticals Inc
  32. 7.6.1 Regeneron Pharmaceuticals Inc Company Information
  33. 7.6.2 Regeneron Pharmaceuticals Inc Business Overview
  34. 7.6.3 Regeneron Pharmaceuticals Inc Transthyretin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Regeneron Pharmaceuticals Inc Transthyretin Product Portfolio
  36. 7.6.5 Regeneron Pharmaceuticals Inc Recent Developments
  37. 7.7 Pfizer Inc
  38. 7.7.1 Pfizer Inc Company Information
  39. 7.7.2 Pfizer Inc Business Overview
  40. 7.7.3 Pfizer Inc Transthyretin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Inc Transthyretin Product Portfolio
  42. 7.7.5 Pfizer Inc Recent Developments
8 North America
  1. 8.1 North America Transthyretin Market Size by Type
  2. 8.1.1 North America Transthyretin Revenue by Type (2021-2032)
  3. 8.1.2 North America Transthyretin Sales by Type (2021-2032)
  4. 8.1.3 North America Transthyretin Price by Type (2021-2032)
  5. 8.2 North America Transthyretin Market Size by Application
  6. 8.2.1 North America Transthyretin Revenue by Application (2021-2032)
  7. 8.2.2 North America Transthyretin Sales by Application (2021-2032)
  8. 8.2.3 North America Transthyretin Price by Application (2021-2032)
  9. 8.3 North America Transthyretin Market Size by Country
  10. 8.3.1 North America Transthyretin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Transthyretin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Transthyretin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Transthyretin Market Size by Type
  2. 9.1.1 Europe Transthyretin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Transthyretin Sales by Type (2021-2032)
  4. 9.1.3 Europe Transthyretin Price by Type (2021-2032)
  5. 9.2 Europe Transthyretin Market Size by Application
  6. 9.2.1 Europe Transthyretin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Transthyretin Sales by Application (2021-2032)
  8. 9.2.3 Europe Transthyretin Price by Application (2021-2032)
  9. 9.3 Europe Transthyretin Market Size by Country
  10. 9.3.1 Europe Transthyretin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Transthyretin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Transthyretin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Transthyretin Market Size by Type
  2. 10.1.1 China Transthyretin Revenue by Type (2021-2032)
  3. 10.1.2 China Transthyretin Sales by Type (2021-2032)
  4. 10.1.3 China Transthyretin Price by Type (2021-2032)
  5. 10.2 China Transthyretin Market Size by Application
  6. 10.2.1 China Transthyretin Revenue by Application (2021-2032)
  7. 10.2.2 China Transthyretin Sales by Application (2021-2032)
  8. 10.2.3 China Transthyretin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Transthyretin Market Size by Type
  2. 11.1.1 Asia Transthyretin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Transthyretin Sales by Type (2021-2032)
  4. 11.1.3 Asia Transthyretin Price by Type (2021-2032)
  5. 11.2 Asia Transthyretin Market Size by Application
  6. 11.2.1 Asia Transthyretin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Transthyretin Sales by Application (2021-2032)
  8. 11.2.3 Asia Transthyretin Price by Application (2021-2032)
  9. 11.3 Asia Transthyretin Market Size by Country
  10. 11.3.1 Asia Transthyretin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Transthyretin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Transthyretin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Transthyretin Market Size by Type
  2. 12.1.1 SAMEA Transthyretin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Transthyretin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Transthyretin Price by Type (2021-2032)
  5. 12.2 SAMEA Transthyretin Market Size by Application
  6. 12.2.1 SAMEA Transthyretin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Transthyretin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Transthyretin Price by Application (2021-2032)
  9. 12.3 SAMEA Transthyretin Market Size by Country
  10. 12.3.1 SAMEA Transthyretin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Transthyretin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Transthyretin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Transthyretin Value Chain Analysis
  2. 13.1.1 Transthyretin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Transthyretin Production Mode & Process
  6. 13.2 Transthyretin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Transthyretin Distributors
  9. 13.2.3 Transthyretin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst